GMO (Jeremy Grantham)
GMO (Jeremy Grantham) (Grantham, Mayo, Van Otterloo & Co. LLC) reported 683 positions worth $46.61B as of September 30, 2026 (13F filed November 13, 2026). Largest holding: MSFT (7.5%). Biggest move: new buy SPCX ($728.6M).
| # | Symbol | Company | Value ↓ | % Port. | Time Held | Shares | Est. Buy Price | Gain | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ▸ 1 | MSFT | $3.49B | 7.49% | >10 Years | 6,808,753 | $287.98* | +79.9% | — | — | +1.0% | |
| ▸ 2 | META | $2.28B | 4.90% | 8.8 Years | 3,148,152 | $395.42 | +58.4% | — | — | -13.6% | |
| ▸ 3 | GOOGL | $2.13B | 4.57% | >10 Years | 6,192,734 | $111.73* | +153.9% | — | — | -17.5% | |
| ▸ 4 | AAPL | $2.01B | 4.31% | >10 Years | 6,028,178 | $141.79* | +148.8% | — | — | +5.9% | |
| ▸ 5 | TMO | $2.00B | 4.30% | 2.5 Years | 2,966,718 | $525.67 | +31.5% | — | — | +2.4% | |
| ▸ 6 | JNJ | $1.84B | 3.95% | >10 Years | 6,956,949 | $152.77* | +85.0% | — | — | +6.7% | |
| ▸ 7 | AMZN | $1.56B | 3.34% | 8.3 Years | 6,251,591 | $173.47 | +48.6% | — | — | +3.5% | |
| ▸ 8 | LRCX | $1.54B | 3.31% | 5 Years | 4,697,045 | $76.85 | +174.3% | — | — | -35.8% | |
| ▸ 9 | TXN | $1.31B | 2.82% | >10 Years | 4,686,735 | $147.40* | +99.6% | — | — | +5.0% | |
| ▸ 10 | V | $1.22B | 2.62% | 9.3 Years | 3,393,457 | $259.35 | +64.4% | — | — | +18.7% |
Related managers
Five closest superinvestors by Jaccard overlap of tickers held in the latest quarter (computed nightly).
| Manager | Overlap | Shared holdings |
|---|---|---|
| Bridgewater Associates (Ray Dalio) | 22.8% | BMY, BF-B, CI, CVS, CPB, CAT, CVX, CIEN +104 |
| Citadel Advisors (Ken Griffin) | 22.7% | BMY, CI, CVS, CPB, CAT, CVX, C, KO +140 |
| Two Sigma Investments | 21.5% | BMY, CI, CVS, CM, CNI, CAT, CVX, C +130 |
| Millennium Management | 21.1% | BMY, CI, CVS, CPB, CAT, CX, CVX, C +137 |
| D.E. Shaw & Co | 20.6% | BMY, CI, CVS, CAT, CVX, C, KO, CTSH +112 |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does GMO (Jeremy Grantham) hold as of Q3 2026?
GMO (Jeremy Grantham) reported 683 positions worth $46.61B in its Q3 2026 13F filing. Largest positions: MSFT (7.5%), META (4.9%), GOOGL (4.6%), AAPL (4.3%) and TMO (4.3%).
What did GMO (Jeremy Grantham) buy in Q3 2026?
New positions: SPCX, SYK, MLM, HD and DRES (101 in all). Added to: PM, NFLX, TMO, SNPS and TTE (123 in all).
What did GMO (Jeremy Grantham) sell in Q3 2026?
Reduced: CRM, AAPL, MRK, LRCX and META (111 in all). Sold out entirely: WED, EXMOC, BTI, VALE and 8L8C (79 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.